drug development trends report 2023 quantumrun foresight

Drug Development: Trends Report 2023, Quantumrun Foresight

In this report section, we take a closer look at the drug development trends Quantumrun Foresight is focusing on in 2023, which have seen significant advancements recently, particularly in vaccine research. The COVID-19 pandemic accelerated the development and distribution of vaccines and necessitated the introduction of various technologies into this field. For instance, artificial intelligence (AI) has played a crucial role in drug development, enabling faster and more accurate analysis of large amounts of data. 

Moreover, AI-powered tools, such as machine learning algorithms, can identify potential drug targets and predict their effectiveness, streamlining the drug discovery process. Despite its many benefits, there remain ethical concerns surrounding the use of AI in drug development, such as the potential for biased results.

Click here to explore more category insights from Quantumrun Foresight’s 2023 Trends Report.

In this report section, we take a closer look at the drug development trends Quantumrun Foresight is focusing on in 2023, which have seen significant advancements recently, particularly in vaccine research. The COVID-19 pandemic accelerated the development and distribution of vaccines and necessitated the introduction of various technologies into this field. For instance, artificial intelligence (AI) has played a crucial role in drug development, enabling faster and more accurate analysis of large amounts of data. 

Moreover, AI-powered tools, such as machine learning algorithms, can identify potential drug targets and predict their effectiveness, streamlining the drug discovery process. Despite its many benefits, there remain ethical concerns surrounding the use of AI in drug development, such as the potential for biased results.

Click here to explore more category insights from Quantumrun Foresight’s 2023 Trends Report.

Curated by

  • Quantumrun

Last updated: 29 April 2024

  • | Bookmarked links: 17
Insight posts
Nootropics: Wonder drugs or marketing gimmick?
Quantumrun Foresight
Nootropics might be the answer to improving cognitive function, memory, and decision-making prowess in healthy individuals.
Insight posts
Obesity drugs: Patients can lose 15 percent of body weight by taking this drug
Quantumrun Foresight
Wegovy by Danish pharma company. Novo Nordisk. got the US Food and Drug Administration approval for weight management.
Insight posts
CBD-infused products: Miracle compound or just another health fad?
Quantumrun Foresight
CBD, a cannabis-derived compound, is popping up in everything from mineral water to honey.
Insight posts
Opioid crisis: Pharmaceutical companies worsen epidemic
Quantumrun Foresight
Direct advertisements by pharmaceutical companies have led to the over-prescription of opioids, causing a modern-day opioid crisis.
Insight posts
LSD pain relief: Clinical study reveals hidden benefits of LSD
Quantumrun Foresight
No longer a party favor of the 60s, LSD promises pain relief in microdoses.
Insight posts
Molecular farming vaccines: A plant-based alternative to vaccines developed in bioreactors
Quantumrun Foresight
Edible plant-based therapeutics could become the new form of vaccination, courtesy of molecular farming development.
Insight posts
Eye drop for vision: Eye drops could soon become a treatment for age-induced farsightedness
Quantumrun Foresight
Two eye drops could become a new way to manage presbyopia provide hope to those with farsightedness.
Insight posts
Peanut allergy therapy: A saving grace for children with peanut allergies powered by science
Quantumrun Foresight
Thanks to peanut allergy therapy, scientists believe that people with a peanut allergy may be able to consume peanuts without fear of a life-threatening reaction.
Insight posts
AI antibiotics: How artificial intelligence algorithms are identifying new types of antibiotics
Quantumrun Foresight
Impeccable timing for healthcare industry as application of AI to find new antibiotics could positively benefit millions worldwide.
Insight posts
Newgen mRNA: Quick and effective vaccines at a lower cost
Quantumrun Foresight
Because of mRNA technology, COVID-19 vaccines were developed in record time. It may provide the gateway to developing flu, malaria, or HIV vaccines.
Insight posts
Lyme disease vaccine: Eradicating Lyme disease as it grows like wildfire
Quantumrun Foresight
Cases of Lyme disease are growing annually as the warming climate allows disease-carrying ticks to travel beyond their normal habitats.
Insight posts
Marijuana pain relief: A safer alternative to opioids
Quantumrun Foresight
Cannabis products containing a high concentration of cannabidiol may help with chronic pain management.
Insight posts
DIY medicine: The rebellion against Big Pharma
Quantumrun Foresight
Do-it-yourself (DIY) medicine is a movement being driven by some members of the scientific community protesting “unjust” price hikes placed on life-saving medication by large pharmaceutical companies.
Insight posts
Alzheimer's vaccine: A possible way to prevent the long goodbye
Quantumrun Foresight
An Alzheimer's vaccine may soon hit the shelves, potentially saving millions of lives.
Insight posts
AI-first drug discovery: Can robots help scientists discover new pharma drugs?
Quantumrun Foresight
Pharmaceutical companies are creating their own AI platforms to rapidly develop new drugs and treatments.
Insight posts
Cannabusiness tech: In support of the growing cannabis empire
Quantumrun Foresight
Cannabusinesses are investigating employing devices and software to automate their processes and fast-track commercialization.
Insight posts
Optimized psychedelic therapies: Curating drugs to create the best therapies
Quantumrun Foresight
Biotech firms are modifying psychedelic drugs to address specific mental health disorders.